Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Royal Marsden NHS Foundation Trust
West China Hospital
University of Chicago
DEKA Biosciences
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute
University of Colorado, Denver
University of Birmingham
University of Chicago
The Netherlands Cancer Institute
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
University of Cincinnati
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The Netherlands Cancer Institute
University of Cincinnati
University of Colorado, Denver
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Curis, Inc.
Traws Pharma, Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Miami
University Health Network, Toronto
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)